Jiuzhou Pharmaceutical: The development plan for 2026 will accelerate the landing of small nucleic acid production capacity.

On April 24th, Jiuzhou Pharmaceutical stated in a conference call that small nuclear acids are a key area of focus for the company. Currently, the company has established a small nuclear acid research and development platform, with a relatively small business volume. The development plan for 2026 will accelerate the establishment of small nuclear acid production capacity.